BAC and Octapharma to develop custom ligand for recombinant plasma protein(03/18/2008) BAC BV announced that it has entered into a collaboration with Octapharma AG. The objective of the collaboration is to discover and develop a custom CaptureSelect(r) ligand for the purification of a recombinant Factor IX product, developed by ...
Top
